Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril

References

• Agoram B, Woltosz WS, Bolger MB. (2001). Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev 50:S41–S67.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Sinko PJ, Fleisher D. (1988). Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 5:65l–4.
   Web of Science ®Google Scholar
• Bermejo M, Merino V, Garrigues TM, et al. (1999). Validation of a biophysical drug absorption model by the PATQSAR system. J Pharm Sci 88:398–405.
   PubMed Web of Science ®Google Scholar
• Bermejo M, Paixao P, Hens B, et al. (2018). Linking the gastrointestinal behavior of ibuprofen with the systemic exposure between and within humans-part 1: fasted state conditions. Mol Pharm 15:5454–67.
   PubMed Web of Science ®Google Scholar
• Carmona-Ibanez G, Bermejo-Sanz MD, Rius-Alarco F, et al. (1999). Experimental studies on the influence of surfactants on intestinal absorption of drugs – cefadroxil as model drug and sodium taurocholate as natural model surfactant: studies in rat colon and in rat duodenum. Arzneimittel Forschung Drug Res 49: 44–50.
   PubMed Web of Science ®Google Scholar
• Carslaw HS, Jaeger JC. (1959). Conduction of heat in solids. 2nd ed. Oxford: Oxford University Press.
   Google Scholar
• Chanker LS. (1960). On the mechanism of absorption of drugs from the gastrointestinal tract. J Med Pharm Chem 2:343–59.
   PubMedGoogle Scholar
• Chrenova J, Durisova M, Mircioiu C, Dedik L. (2010). Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine. Methods Find Exp Clin Pharmacol 32:413–9.
   PubMedGoogle Scholar
• Chung J, Kesisoglou F. (2018). Physiologically based oral absorption modelling to study gut-level drug interactions. J Pharm Sci 107:18–23.
   PubMed Web of Science ®Google Scholar
• Crommelin D, Meibohm B, Sindelar R. 2008. Pharmaceutical biotechnology: fundamentals and applications. 3rd ed. Informa Healthcare. New York, London.
   Google Scholar
• Dressman JB, Amidon GJ, Fleisher D. (1985). Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci 74:588–9.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Fleisher D, Amidon GL. (1984). Physicochemical model for dose-dependent drug absorption. J Pharm Sci 73:1274–9.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Fleisher D. (1986). Mixing-tank model for predicting dissolution rate control or oral absorption. J Pharm Sci 75:109–16.
   PubMed Web of Science ®Google Scholar
• Enobong EJ, Abasiekwerev UA. (2018). Mathematical model of the role of peristalsis in intestinal drug absorption. Int J Innov Sci Res Technol 3:403–8.
   Google Scholar
• González‐Alvarez I, Fernández‐Teruel C, Casabó‐Alós V, et al. (2007). In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results. Biopharm Drug Dispos 28(5):229–39.
   PubMed Web of Science ®Google Scholar
• Guse C, Koennings S, Kreye F, et al. (2006). Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. Int J Pharm 314:137–44.
   PubMed Web of Science ®Google Scholar
• Hens B, Bermejo M, Tsume Y, et al. (2018). Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in vitro-in silico-in vivo approach. Eur J Pharm Sci 115:258–69.
   PubMed Web of Science ®Google Scholar
• Hens B, Tsume Y, Bermejo M, et al. (2017). Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs. Mol Pharm 14: 4281–94.
   PubMed Web of Science ®Google Scholar
• Hintz RJ, Johnson KC. (1989). The effect of particle size distribution on the dissolution rate and oral absorption. Int J Pharm 51:9–17.
   Web of Science ®Google Scholar
• Lennernäs H. (2007). Intestinal permeability and its relevance for absorption and elimination. Xenobiotica 37:1015–51.
   PubMed Web of Science ®Google Scholar
• Lin L, Wong H. (2017). Predicting oral drug absorption: mini review on physiologically-based pharmacokinetic models. Pharmaceutics 9:41.
   PubMed Web of Science ®Google Scholar
• Lozoya-Agullo I, Zur M, Beig A, et al. (2016). Segmental-dependent permeability throughout the small intestine following oral drug administration: single-pass vs. Doluisio approach to in-situ rat perfusion. Int J Pharm 515:201–8.
   PubMed Web of Science ®Google Scholar
• Macheras P, Iliadis A, Melagraki G. (2018). A reaction limited in vivo dissolution model for the study of drug absorption: towards a new paradigm for the biopharmaceutic classification of drugs. Eur J Pharm Sci 117:98–106.
   PubMed Web of Science ®Google Scholar
• Macheras P, Symillides MY. (1989). Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm Drug Dispos 10:43–53.
   PubMed Web of Science ®Google Scholar
• Mager DE, Wyska E, Jusko WJ. (2003). Diversity of mechanism-based pharmacodynamic models. Drug Metab Dispos 31:510–8.
   PubMed Web of Science ®Google Scholar
• Manallack DT. (2007). The pKa distribution of drugs: application to drug discovery. Perspect Medicin Chem 1:25–38.
   PubMedGoogle Scholar
• Medvedovici A, Albu F, Sora ID, et al. (2009). Assay of free captopril in human plasma as monobromobimane derivative, using RPLC/(+)ESI/MS/MS: validation aspects and bioequivalence evaluation. Biomed Chromatogr 23:1092–100.
   PubMed Web of Science ®Google Scholar
• Miclea LM, Vlaia L, Vlaia V, et al. (2010). Preparation and characterisation of inclusion complexes of meloxicam and Α-cyclodextrin and Β-cyclodextrin. Farmacia 58:583–93.
   Web of Science ®Google Scholar
• Mircioiu I, Anuta V, Purcaru SO, et al. (2013a). In vitro dissolution of poorly soluble drugs in the presence of surface active agents – in vivo pharmacokinetics correlations. II. Nimesulide. Farmacia 61:88–102.
   Web of Science ®Google Scholar
• Mircioiu I, Anuta V, Ibrahim N, Mircioiu C. (2012). Dissolution of tamoxifen in biorelevant media. A two-phase release model. Farmacia 60:315–24.
   Web of Science ®Google Scholar
• Mircioiu C, Mircioiu I, Voicu V, Miron D. (2005). Dissolution-bioequivalence non-correlations. Basic Clin Pharmacol Toxicol 96:262–4.
   PubMed Web of Science ®Google Scholar
• Mircioiu C, Voicu VA, Ionescu M, et al. (2013b). Evaluation of in vitro absorption, decontamination and desorption of organophosphorous compounds from skin and synthetic membranes. Toxicol Lett 219:99–106.
   PubMed Web of Science ®Google Scholar
• Mircioiu C, Voicu V, Miron D, Mircioiu I. (2005). Non-standard correlations: in vitro in vivo correlations for immediate release products: comparison of different bioequivalence experiments. Basic Clin Pharmacol Toxicol 96:259–61.
   PubMed Web of Science ®Google Scholar
• Ni PF, Ho NFH, Fox JF. (1980). Theoretical model studies of intestinal drug absorption v: nonsteady-state fluid flow and absorption. Int J Pharm 5:33–47.
   Web of Science ®Google Scholar
• Oberle RL, Amidon GL. (1987). The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine, An explanation for the double peak phenomenon. J Pharmacokin Biopharm 15:S29–S44.
   Google Scholar
• Pahomi G, Corlan G, Anuta V, et al. (2012). Study of the influence of bile salts and lecithin on distribution of ketoconazole between plasma and methylene chloride. Farmacia 60:809–21.
   Web of Science ®Google Scholar
• Paolino D, Tudose A, Celia C, et al. (2019). Mathematical models as tools to predict the release kinetic of fluorescein from lyotropic colloidal liquid crystals. Materials 12:693.
   PubMed Web of Science ®Google Scholar
• Pereira CM, Tam YK, Coe JY, et al. (1996). Pharmacokinetic-pharmacodynamic modelling for captopril in healthy anaesthetized piglets. Biopharm Drug Dispos 17:365–72.
   PubMed Web of Science ®Google Scholar
• Perez MAC, Diaz HG, Teruel CF, et al. (2002). A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment. Eur J Pharm Biopharm 53:317–25.
   PubMed Web of Science ®Google Scholar
• Prasacu I, Mircioiu C, Sandulovici R, Enache F. (2009). Release of metoprolol from solid dosage forms. choice and validation of theoretical model. Farmacia 57:89–98.
   Web of Science ®Google Scholar
• Preda IA, Mircioiu I, Mircioiu C, et al. (2012). Research concerning the development of a biorelevant dissolution test for formulations containing norfloxacin. I. Modelling of in vitro release kinetics. Farmacia 60:675–87.
   Web of Science ®Google Scholar
• Sandulovici R, Prasacu I, Mircioiu C, et al. (2009). Mathematical and phenomenological criteria in selection of pharmacokinetic model for M1 metabolite of pentoxyphylline. Farmacia 57:235–46.
   Web of Science ®Google Scholar
• Savu SN, Silvestro L, Surmeian M, et al. (2016). Evaluation of clopidogrel conjugation metabolism: PK studies in man and mice of clopidogrel acyl glucuronide, drug metabolism and disposition. Drug Metab Dispos 44:1490–7.
   PubMed Web of Science ®Google Scholar
• Sinko PJ, Leesman GD, Amidon GL. (1991). Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm Res 8:979–88.
   PubMed Web of Science ®Google Scholar
• Sugano K, Kansy M, Artursson P, et al. (2010). Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 9:597–614.
   PubMed Web of Science ®Google Scholar
• Suta LM, Vlaia L, Fulias A, et al. (2013). Evaluation study of the inclusion complexes of some oxicams with 2-hydroxypropyl-beta-cyclodextrin. Rev Chim 64:1279–83.
   Web of Science ®Google Scholar
• Tvrdonova M, Dedik L, Mircioiu C, et al. (2009). Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings. Basic Clin Pharmacol Toxicol 104:35–42.
   PubMed Web of Science ®Google Scholar
• Vertzoni M, Augustijns P, Grimm M, et al. (2019). Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. Eur J Pharm Sci 134:153–75.
   PubMed Web of Science ®Google Scholar
• Wan H, Ulander J. (2006). High-throughput pKa screening and prediction amenable for ADME profiling. Expert Opin Drug Metab Toxicol 2:39–55.
   Web of Science ®Google Scholar
• Yu LX, Lipka E, Crison JR, Amidon GJ. (1996). Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Delivery Rev 19:359–76.
   PubMed Web of Science ®Google Scholar